Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
FORM SD
Regulatory Filings Classification · 85% confidence The document is an SEC Form SD (Specialized Disclosure Report) filed under Rule 13p-1 to disclose conflict minerals sourcing. It is a specialized regulatory compliance filing rather than an annual or quarterly report, proxy, or ESG narrative report. There is no dedicated category for a conflict minerals Form SD, so it falls into the ‘Regulatory Filings’ fallback category.
2026-06-01 English
FORM 8-K
Regulatory Filings Classification · 92% confidence The document is a Form 8-K current report under the Securities Exchange Act. It does not contain substantive financial statements or actual financial data, nor is it a presentation, earnings release, or detailed management discussion. It is a short regulatory filing notifying of an attached press release (Exhibit 99.1). This falls into the general category of regulatory announcements and miscellaneous compliance filings. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-21 English
FORM 8-K
Regulatory Filings Classification · 85% confidence The document is a Form 8-K “Current Report” under the Securities Exchange Act, with Item 8.01 “Other Events” describing a press release about an external study publication and exhibit filings. It does not present financial results (ER/IR), governance changes (MANG), M&A activity (MA), or any other specific category. It is a generic SEC regulatory filing, so it falls under the fallback category Regulatory Filings (RNS).
2026-05-14 English
8-K - Apyx Medical Corp (0000719135) (Filer)
Regulatory Filings Classification · 90% confidence The document is a U.S. SEC Form 8-K "Current Report" under Sections 13/15(d) of the Exchange Act, specifically Item 8.01 “Other Events” describing an FDA clearance press release. It contains no financial statements or earnings data, nor does it announce management changes, dividends, or mergers. As a standalone SEC event-reporting form not fitting other specific categories, it falls under the general regulatory filing catchall. Therefore, it should be classified as Regulatory Filings (RNS).
2026-05-11 English
FORM 10-Q
Interim / Quarterly Report Q1 2026
2026-05-07 English
8-K - Apyx Medical Corp (0000719135) (Filer)
Regulatory Filings
2026-05-07 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.